已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Icodextrin is Associated with a Lower Mortality Rate in Peritoneal Dialysis Patients

二十碳糊精 腹膜透析 医学 死亡率 内科学 泌尿科 肾脏疾病 胃肠病学 重症监护医学 外科
作者
Ju‐Yeh Yang,Likwang Chen,Yu‐Sen Peng,Yun-Yi Chen,Jenq‐Wen Huang,Kuan‐Yu Hung
出处
期刊:Peritoneal Dialysis International [SAGE Publishing]
卷期号:39 (3): 252-260 被引量:10
标识
DOI:10.3747/pdi.2018.00217
摘要

Background Icodextrin (ICO) improves fluid removal in peritoneal dialysis (PD) patients. However, whether physiological benefits of ICO translate into patient survival remains unclear. We examine the association of ICO and clinical outcomes. Methods We identified patients who initiated long-term PD from the National Health Insurance Research Database of Taiwan. We matched ICO users with non-users according to propensity score and survival status when ICO was prescribed. We utilized time-dependent analyses to avoid immortal time bias. Additional competing risk models were utilized for the outcomes except for death. The outcomes of interest were time to death, technique failure, peritonitis, major adverse cardiovascular events (MACE), and hospitalization. Results A total of 4,914 PD patients were enrolled and 2,836 PD patients (57.7%) were identified as ICO users. The ICO users had significantly better overall survival (hazard ratio [HR] 0.74; 95% confidence interval [CI] 0.63 – 0.86), especially among early ICO users (HR 0.64; 95% CI 0.54 – 0.77, p value for interaction: 0.007). The ICO users were associated with higher risk of peritonitis (subdistribution HR 1.22, 95% CI 1.06 – 1.14) and hospitalization (subdistribution HR 1.14, 95% CI 1.05 – 1.24), considering competing risk of death. However, when considering ICO use as a time-varying covariate, ICO users shared similar risks for technique failure, peritonitis, MACE, and hospitalization as non-users. The effect of ICO on mortality was especially prominent among those early users. Conclusions After adjustments for immortal time biases, ICO users were significantly associated with approximately 20% reduction in mortality, especially among early users.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
明时完成签到,获得积分10
1秒前
3秒前
3秒前
笨笨的寄真完成签到 ,获得积分10
4秒前
Becky完成签到 ,获得积分10
4秒前
7秒前
零知识完成签到 ,获得积分10
7秒前
伽拉发布了新的文献求助10
13秒前
洸彦完成签到 ,获得积分10
15秒前
CipherSage应助G1997采纳,获得10
15秒前
Ethan完成签到 ,获得积分0
16秒前
16秒前
Rondab应助科研通管家采纳,获得10
17秒前
科研通AI2S应助科研通管家采纳,获得10
18秒前
18秒前
CipherSage应助科研通管家采纳,获得10
18秒前
Rondab应助科研通管家采纳,获得10
18秒前
Rondab应助科研通管家采纳,获得10
18秒前
SciGPT应助科研通管家采纳,获得10
18秒前
SciGPT应助科研通管家采纳,获得10
18秒前
18秒前
明钟达完成签到 ,获得积分10
21秒前
domingo发布了新的文献求助20
21秒前
HughWang完成签到,获得积分10
24秒前
嘟嘟豆806完成签到 ,获得积分10
26秒前
29秒前
火星完成签到 ,获得积分10
29秒前
31秒前
研友_Zlx3aZ发布了新的文献求助10
33秒前
认真的三问完成签到,获得积分20
35秒前
kyfbrahha完成签到 ,获得积分10
36秒前
36秒前
maleo发布了新的文献求助30
39秒前
domingo完成签到,获得积分10
40秒前
一直向前发布了新的文献求助10
40秒前
希望天下0贩的0应助Unicorn采纳,获得50
41秒前
toto完成签到 ,获得积分10
41秒前
宣灵薇完成签到,获得积分0
42秒前
42秒前
46秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989957
求助须知:如何正确求助?哪些是违规求助? 3532034
关于积分的说明 11256000
捐赠科研通 3270880
什么是DOI,文献DOI怎么找? 1805070
邀请新用户注册赠送积分活动 882252
科研通“疑难数据库(出版商)”最低求助积分说明 809216